Literature DB >> 16380629

MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase.

K Ohta1, K Shigemoto, S Kubo, N Maruyama, Y Abe, N Ueda, A Fujinami, M Ohta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380629     DOI: 10.1212/01.wnl.0000188881.46043.44

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

Authors:  Maria I Leite; Margaret Jones; Philipp Ströbel; Alexander Marx; Ralf Gold; Erik Niks; Jan J G M Verschuuren; Sonia Berrih-Aknin; Francesco Scaravilli; Aurea Canelhas; B Paul Morgan; Angela Vincent; Nick Willcox
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

2.  Induction of myasthenia by immunization against muscle-specific kinase.

Authors:  Kazuhiro Shigemoto; Sachiho Kubo; Naoki Maruyama; Naohito Hato; Hiroyuki Yamada; Chen Jie; Naoto Kobayashi; Katsumi Mominoki; Yasuhito Abe; Norifumi Ueda; Seiji Matsuda
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

Review 3.  Myasthenia gravis induced by autoantibodies against MuSK.

Authors:  K Shigemoto
Journal:  Acta Myol       Date:  2007-12

4.  Detection and characterization of estradiol (E2) and unconjugated estriol (uE3) immunoassay interference due to anti-bovine alkaline phosphatase (ALP) antibodies.

Authors:  Anu S Maharjan; Sara P Wyness; Julie A Ray; Tanya L Willcox; Jonathan D Seiter; Jonathan R Genzen
Journal:  Pract Lab Med       Date:  2019-08-29

5.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.